The overdose crisis — coupled with a lack of accessible harm reduction services — represents a growing concern for young queer and trans men who use drugs.
Articles on Opioids
Displaying 121 - 140 of 222 articles
The crisis has made recovery more difficult for those with substance use disorders. The inability to get to support group meetings, stress and illness are just some of the factors.
A new report counts the social costs of pharmaceutical opioid misuse and illegal opioid use in Australia for 2015/2016. The numbers are fairly grim.
Pharmacists are well positioned to provide communities with a lifesaving drug.
Taking tranquilizers with opioids increases the risk of overdose tenfold.
Aggressive marketing of prescription opioids by pharmaceutical companies provided doctors with scant information about potential harmful effects.
Urgently needed treatment for opioid use disorder is often denied to incarcerated people, feeding the crisis in prisons and jails.
Fentanyl has been a prime culprit in the opioid crisis in the United States. It’s now turning up in cocaine and methamphetamine in New South Wales.
In 2016, drug misuse was cited as the top concern among New Hampshire voters. What remedies are the Democratic primary contenders putting forward to combat the opioid crisis?
From colonial poppy fields to pharmatrash, southern Africa offers a fascinating history of drug regimes – one that helps us make sense of drug policies and legislation today.
Treatments for opioid dependence, such as methadone and buprenorphine, are effective. But some people who stand to benefit are missing out.
Opioid overdoses killed 47,000 Americans in 2017 — more than gun violence. Many fewer would have died if they’d been treated with the life-saving drug naloxone, also called Narcan.
Artificial intelligence holds great promise for medicine, but safeguards are needed to ensure it does not harm patients.
While critics accuse companies facing lots of lawsuits of using bankruptcy as a sort of ‘get of jail free card,’ the reality of the legal procedure is more complicated.
Previously secret documents and data make it clear that many companies engaged in the distribution of prescription painkillers either skirted or ignored their legal obligations for years.
State governments are leading the charge against opioid makers over their role in the epidemic. A team of researchers at Penn State examined just how much the crisis has cost them.
With the opioid crisis there is no doubt that physicians need safer, nonaddictive pain killers. Now new insights on how to create these are coming from an unlikely source: the naked mole rat.
In the midst of a public health crisis, with increasing rates of death from opioid overdose, the Ontario government is clawing back life-saving measures.
A policy response focused on reducing prescription opioids will not resolve North America’s opioid crisis. And it is hurting many adults who live with otherwise unbearable chronic pain.
The $270 million settlement may not mean a whole lot if Purdue files for bankruptcy as it’s reportedly considering.
Top contributors
-
Professor and Deputy Director, Monash Addiction Research Centre, Monash University
-
Professor, Institute for Musculoskeletal Health, University of Sydney
-
Professor of Neuropharmacology, University of Lancashire
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Professor, Sydney School of Public Health, University of Sydney
-
Medical Director of Opioid Policy Research, Brandeis University
-
Professor of Geography, Penn State
-
Associate Professor of Sociology, Bentley University
-
Associate Professor of Emergency Medicine, Thomas Jefferson University
-
Adjunct Professor at the National Drug Research Institute (Melbourne based), Curtin University
-
Honorary Fellow, Department of Health Sciences, University of York
-
Associate Professor, School of Public Health, University of Sydney
-
Professor of Law, Indiana University
-
Senior Lecturer in Criminology, UNSW
-
Professor, National Drug Research Institute, Curtin University and Burnet Institute, Burnet Institute